A detailed description of antimetabolites (methotrexate, fluorouracil,
capecitabine, gemcitabine, pemetrexed) that are currently used in
routine therapy or are in clinical trials in breast cancer patients.
In « Molecular Therapy of Breast Cancer: Classicism Meets Modernity ».
by Marc Lacroix
InTextoResearch, Baelen (Liège, Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60741-593-0